Warfarin Sodium Tablet
Product Images NDC 70518-4722

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Warfarin Sodium (NDC 70518-4722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Warfarin Sodium 3 mg oral tablet label showing quantity of 1 tablet. The label includes warnings about serious bleeding from overdosage, storage instructions at 20-25°C with permitted excursions, and notes it is highly potent anticoagulant. Manufactured by Taro Pharma, Israel, and repackaged by RemedyRepack Inc., Indiana, PA.*

FDA Label Image

Mm1 (Warfarin Sodium 3mg 70518 4722 00)

Warfarin Sodium 3 mg oral tablet label showing a 100-count package by RemedyRepack Inc. The label notes it as a highly potent anticoagulant and RX only. Manufacturer information lists Taro Pharma, Haifa Bay, Israel, with storage instructions and warnings about serious bleeding from overdose.*

FDA Label Image

Chemical Structure (Warfarin 01)

Chemical structure of Warfarin Sodium showing a coumarin derivative with a sodium ion, a benzene ring, and an acetyl side group, consistent with the active ingredient Warfarin Sodium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.